0001683168-21-003663.txt : 20210816 0001683168-21-003663.hdr.sgml : 20210816 20210816112844 ACCESSION NUMBER: 0001683168-21-003663 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 EFFECTIVENESS DATE: 20210816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Organicell Regenerative Medicine, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 474180540 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-410100 FILM NUMBER: 211175702 BUSINESS ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 BUSINESS PHONE: 888-963-7881 MAIL ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Products Services & Research, Inc. DATE OF NAME CHANGE: 20150917 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 D 1 primary_doc.xml X0708 D LIVE 0001557376 Organicell Regenerative Medicine, Inc. 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL FLORIDA 33140 888-963-7881 NEVADA None Biotech Products Services & Research, Inc. BESPOKE TRICYCLES INC Corporation true Albert Mitrani 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Executive Officer Director Ian Bothwell 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Executive Officer Director Maria Ines Mitrani 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Executive Officer Director George Shapiro 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Executive Officer Director Allen Meglin 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Director Michael Carbonara 4045 Sheridan Avenue, Suite 239 Miami Beach FL FLORIDA 33140 Director Biotechnology $1,000,001 - $5,000,000 06b false 2021-08-02 false true false 0 500000 500000 0 false 1 0 0 0 false Organicell Regenerative Medicine, Inc. /s/ Ian T. Bothwell Ian T. Bothwell Chief Financial Officer 2021-08-16